Medical devices consolidation continues

Healthcare major Abbott has agreed to buy US medical diagnostics specialist Alere for $5.8 billion (£4 billion), taking control of Alere’s $2.6 billion in debt. The deal strengthens Abbott’s position in point-of-care diagnostics – tests designed to be run in hospitals, doctors’ surgeries or even at home – to support increasingly targeted treatments.

The move is part of a consolidation trend in the medical devices and diagnostics area. Several large suppliers have merged in recent years, including Becton Dickinson with CareFusion and Medtronic with Covidien. More diversified companies such as Baxter and Johnson and Johnson have also split off devices divisions from pharmaceuticals, or cut jobs as technologies mature and the industry becomes more focused.

Related Content

Abbot boosts heart devices with St Jude buyout

6 May 2016 Business

news image

Medical devices consolidation continues with $25bn deal, but Abbott expresses concerns over proposed Alere merger

Faster, cheaper, better

24 September 2014 Premium contentFeature

news image

Microfluidics researchers are aiming to bring new diagnostic devices into mainstream medicine. Mark Peplow reports

Most Commented

Electric choc treatment promises lower fat chocolate

22 June 2016 Research

news image

Problem of reduced fat chocolate gumming up factories’ pipelines overcome

Behind closed doors: How to win the Nobel prize

7 October 2015 Comments

news image

Bengt Norden addresses the myths and rumours surrounding the world's most prestigious science prize